Cargando…
Vaccine Induced Herd Immunity for Control of Respiratory Syncytial Virus Disease in a Low-Income Country Setting
BACKGROUND: Respiratory syncytial virus (RSV) is globally ubiquitous, and infection during the first six months of life is a major risk for severe disease and hospital admission; consequently RSV is the most important viral cause of respiratory morbidity and mortality in young children. Development...
Autores principales: | Kinyanjui, Timothy M., House, Thomas A., Kiti, Moses C., Cane, Patricia A., Nokes, David J., Medley, Graham F. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4577090/ https://www.ncbi.nlm.nih.gov/pubmed/26390032 http://dx.doi.org/10.1371/journal.pone.0138018 |
Ejemplares similares
-
Model evaluation of target product profiles of an infant vaccine against respiratory syncytial virus (RSV) in a developed country setting
por: Kinyanjui, Timothy, et al.
Publicado: (2020) -
Predicting the relative impacts of maternal and neonatal respiratory syncytial virus (RSV) vaccine target product profiles: A consensus modelling approach
por: Pan-Ngum, Wirichada, et al.
Publicado: (2017) -
Duration of shedding of respiratory syncytial virus in a community study of Kenyan children
por: Okiro, Emelda A, et al.
Publicado: (2010) -
Factors associated with increased risk of progression to respiratory syncytial virus-associated pneumonia in young Kenyan children
por: Okiro, Emelda A, et al.
Publicado: (2008) -
Group- and Genotype-Specific Neutralizing Antibody Responses Against
Respiratory Syncytial Virus in Infants and Young Children With Severe
Pneumonia
por: Sande, Charles J., et al.
Publicado: (2013)